From Real Exams Exam Paper
A Level H2 Economics Practice Paper 2
Free Exam-Derived Gemma 4 31B A Level H2 Economics Practice Paper 2 practice paper with questions and answers for Singapore students. This page is rendered as a direct URL so the questions and answers can be discovered without pressing in-page buttons.
These static practice materials are generated from the site's syllabus and paper-generation workflow, with source and model context shown so students and parents can evaluate the material before use.
Questions
TuitionGoWhere Exam Practice (AI)
Subject: Economics H2
Level: A-Level
Paper: Paper 1 (Microeconomics Case Study)
Version: 2 of 5
Duration: 2 hours 15 minutes
Total Marks: 60
Name: ___________________________ Class: __________ Date: __________
Instructions to Candidates
- This paper consists of one Case Study with three sections.
- Answer all questions in the spaces provided.
- Use diagrams where required. Ensure all axes and curves are clearly labeled.
- The total mark for this paper is 60.
Case Study: The Digital Health Diagnostics Market in Singapore
Extract 1 In recent years, the market for AI-driven health diagnostics in Singapore has seen rapid growth. Two major firms, HealthAI and MediScan, dominate the landscape. While both offer similar screening services for chronic diseases, HealthAI has recently acquired a smaller specialized clinic, BioCheck, which holds several patents for early-stage cancer detection. This acquisition has raised concerns among consumer advocacy groups regarding market concentration and the potential for higher pricing.
Extract 2 The demand for these diagnostic services is relatively price-inelastic, as consumers perceive them as essential for life-saving preventative care. However, the cost of providing these services is heavily dependent on the price of high-performance computing (HPC) chips. Global supply chain disruptions have led to a significant increase in the price of these chips over the last 24 months.
Extract 3 The Singapore government is considering intervening in the market. Some policymakers argue that since these diagnostics provide significant positive externalities—reducing the long-term burden on the public healthcare system—the government should provide subsidies to lower the cost for consumers. Others suggest that the market is currently failing due to asymmetric information, as consumers cannot easily distinguish between the quality of different AI diagnostic tools.
Section A: Data Interpretation and Analysis
-
(a) With reference to Extract 2, explain the relationship between the market for HPC chips and the market for AI health diagnostics. [3]
\ -
(b) Using a diagram, explain how an increase in the price of HPC chips affects the equilibrium price and quantity of AI health diagnostics. [4]
\ -
(c) With reference to Extract 2, explain why a firm in this market might be able to pass on the increased cost of HPC chips to consumers without a significant drop in quantity demanded. [3]
\
Section B: Market Structures and Competition
-
(a) Identify the most likely market structure of the AI health diagnostics market in Singapore based on the extracts. Explain your answer. [4]
\ -
(b) Explain how HealthAI and MediScan are likely to compete against one another in this market. [6]
\ -
(c) Discuss whether HealthAI's acquisition of BioCheck will benefit or disadvantage consumers in Singapore. [15]
\
Answers
Marking Scheme: TuitionGoWhere Exam Practice (AI)
Subject: Economics H2 | Paper: Paper 1 (Microeconomics Case Study)
Section A: Data Interpretation and Analysis
1. (a) Relationship between HPC chips and AI health diagnostics [3]
- Identification: HPC chips are a key input (factor of production) for AI health diagnostics. [1]
- Explanation: There is a complementary relationship. An increase in the price of HPC chips increases the marginal cost of providing diagnostic services. [2]
2. (b) Diagram and Effect of Price Increase [4]
- Diagram: Supply and Demand graph. Supply curve shifts left/upwards ( to ). [2]
- Analysis: The shift in supply leads to a higher equilibrium price ( to ) and a lower equilibrium quantity ( to ). [2]
3. (c) Passing on costs (Price Inelasticity) [3]
- Concept: Price Elasticity of Demand (PED) is low/inelastic. [1]
- Reasoning: Consumers perceive the services as essential/life-saving (lack of close substitutes). [1]
- Conclusion: Therefore, a price increase results in a proportionately smaller decrease in quantity demanded, allowing firms to maintain revenue while passing on costs. [1]
Section B: Market Structures and Competition
4. (a) Market Structure [4]
- Identification: Oligopoly. [1]
- Evidence: Extract 1 states "Two major firms, HealthAI and MediScan, dominate the landscape." [2]
- Characteristic: High concentration ratio and high barriers to entry (patents mentioned). [1]
5. (b) Nature of Competition [6]
- Non-Price Competition: Firms are likely to compete via branding, quality of AI accuracy, and specialized services (e.g., the cancer detection patents). [3]
- Interdependence: Because there are only two dominant firms, HealthAI’s pricing or service decisions will directly influence MediScan’s strategy (game theory/strategic interaction). [3]
6. (c) Acquisition of BioCheck: Benefit vs Disadvantage [15]
- Disadvantages (Market Power):
- Increased market concentration higher monopoly power.
- Potential for higher prices due to reduced competition.
- Reduced incentive to innovate if HealthAI becomes too dominant.
- Benefits (Efficiencies):
- Dynamic Efficiency: HealthAI may have more capital to invest in BioCheck's patents, accelerating the development of cancer detection.
- Economies of Scale: Integration may lower average costs through shared infrastructure.
- Evaluation:
- Depends on whether the efficiency gains (better diagnostics) outweigh the allocative inefficiency (higher prices).
- Role of government regulation (e.g., Competition and Consumer Commission of Singapore) in preventing abuse of dominance.